Image courtesy Dr. Ziding Feng Dr. Ziding Feng, a biostatistician in the Public Health Sciences Division, will use his three-year grant to support a research project entitled "Validation of Biomarkers for Prostate Cancer Prognosis."
The Hutchinson Center’s Dr. Ziding Feng has won a 1.2 million grant for prostate cancer studies from the U.S. Department of Defense‘s United States Army Medical Research Acquisition Activity. Feng is one of three Canary Foundation Prostate Team researchers awarded a total of $2.25 million in DOD grants.
Feng, a biostatistician in the Public Health Sciences Division, shares the DOD Prostate Cancer Research Program Synergistic Idea Development Award with Dr. James Brooks of Stanford University.
Feng and Brooks will use the allotted funds over the next three years to support their research project entitled "Validation of Biomarkers for Prostate Cancer Prognosis." They will utilize the Prostate Tissue Microarray Resource with more than 1,000 prostate cancer tissues assembled by the multi-institutional Canary team.
"This DOD grant is to study signals that can distinguish between lethal and indolent prostate cancers, the main research goal of the Canary Prostate Team led by Dr. Pete Nelson at the Center," Feng said.
Feng is a member of the Center’s Biostatistics and Cancer Prevention programs and an affiliate professor in biostatistics at the University of Washington. In addition, Feng is head of the coordinating center of the Early Detection Research Network.
Since 2004 the Canary Foundation has been dedicated in the fight against cancer. To date the nonprofit has generated more than $30 million to help raise awareness about the importance of early detection. To learn more, visit the Canary Foundation website.
[Adapted from a Canary Foundation news release.]